Rayont Inc 's ability to collect accounts receivable sequentially worsen to 1.67, pointing to a challenging and on top of that deteriorating business climate for the Healthcare Facilities industry. Rayont Inc 's Accounts Receivable average collection period in the Mar 31 2023 quarter, has increased to 219 days, from 179 days, in the Dec 31 2022 quarter.

If we take a look into Healthcare sector 609 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2023 from 1558 to 3778.

What is Receivable Turnover Ratio?
What is Rayont Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RAYT Receivables Turnover Ratio	(Mar 31 2023) III. Quarter	(Dec 31 2022) II. Quarter	(Sep 30 2022) I. Quarter	(Jun 30 2022) IV. Quarter	(Mar 31 2022) III. Quarter
Y / Y Receivable Change	646.81 %	203.96 %	260.95 %	204.2 %	-38.24 %
Y / Y Revenue Change	110.98 %	110.48 %	99.07 %	109.12 %	-51.16 %
Receivable Turnover Ratio (TTM)	1.67	2.04	1.93	2.31	3.18
RAYT's Total Ranking	# 3778	# 1558	# 3547	# 3709	# 3613
Accounts Receivable average collection period days	219	179	189	158	115
Seq. Receivable Change	121.19 %	-50.31 %	8.7 %	525.09 %	-9.97 %
Seq. Revenue Change	-30.93 %	3.71 %	35.14 %	117.94 %	-31.09 %

Receivable Turnover Company Ranking
Within:	No.
Healthcare Facilities Industry	# 48
Healthcare Sector	# 610
Overall Market	# 3778

Receivable Turnover Ratio Statistics
High	Average	Low
15.81	5.69	1.4
(Jun 30 2017)		(Mar 31 2023)

RAYT Company Profile • Back to RAYT Efficiency Comparisons • Compare RAYT Receivables Turnover Ratio to its Competitors

Financial Statements
Rayont Inc 's Accounts Receivable	$ 4 Millions	Visit RAYT's Balance sheet
Rayont Inc 's Sales TTM	$ 5 Millions	Visit RAYT's Income Statement
Sources of RAYT's Revenues		Visit RAYT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
RAYT's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
RAYT's Growth Rates	RAYT's Roa	RAYT's Inventory Turnover Ratio	RAYT's Dividend Comparisons
RAYT's Profitability Ratios	RAYT's Roi	RAYT's Asset Turnover Ratio	RAYT's Dividend Growth
RAYT's Valuation Ratios	RAYT's Roe	RAYT's Financial Strength Ratios	RAYT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2023	Receivable at quarter ending Mar 31 2023
Luna Innovations Inc	3.59	$ 112.061 Millions	$ 31.223 Millions
Marinus Pharmaceuticals Inc	3.55	$ 21.672 Millions	$ 6.110 Millions
Abvc Biopharma Inc	3.52	$ 1.072 Millions	$ 0.305 Millions
Assertio Holdings inc	3.51	$ 162.162 Millions	$ 46.260 Millions
Halozyme Therapeutics Inc	3.51	$ 704.980 Millions	$ 201.131 Millions
Nabriva Therapeutics Plc	3.48	$ 36.505 Millions	$ 10.500 Millions
Ginkgo Bioworks Holdings Inc	3.47	$ 390.003 Millions	$ 112.362 Millions
Dr Reddy s Laboratories Limited	3.39	$ 2,992.000 Millions	$ 882.000 Millions
Progyny Inc	3.35	$ 873.090 Millions	$ 260.303 Millions
Pliant Therapeutics Inc	3.32	$ 9.768 Millions	$ 2.938 Millions
Icad Inc	3.30	$ 26.199 Millions	$ 7.948 Millions
Siga Technologies Inc	3.28	$ 108.559 Millions	$ 33.062 Millions
Hyperfine Inc	3.24	$ 7.940 Millions	$ 2.453 Millions
Yubo International Biotech Limited	3.23	$ 0.246 Millions	$ 0.076 Millions
Quantum Cyber N v	3.20	$ 0.679 Millions	$ 0.212 Millions
Sera Prognostics Inc	3.20	$ 0.330 Millions	$ 0.103 Millions
Collegium Pharmaceutical Inc	3.16	$ 596.134 Millions	$ 188.788 Millions
Sensus Healthcare Inc	3.15	$ 37.608 Millions	$ 11.935 Millions
Cardiff Oncology Inc	3.09	$ 2.046 Millions	$ 0.662 Millions
Universal Biosensors Inc	3.00	$ 3.084 Millions	$ 1.028 Millions
Euda Health Holdings Limited	2.96	$ 1.699 Millions	$ 0.573 Millions
Synlogic Inc	2.96	$ 1.110 Millions	$ 0.375 Millions
Smiledirectclub Inc	2.94	$ 438.874 Millions	$ 149.462 Millions
Eagle Pharmaceuticals inc	2.89	$ 267.041 Millions	$ 92.561 Millions
Alimera Sciences Inc	2.88	$ 55.777 Millions	$ 19.377 Millions
Dermtech Inc	2.87	$ 14.277 Millions	$ 4.981 Millions
Cumberland Pharmaceuticals Inc	2.85	$ 40.061 Millions	$ 14.050 Millions
Optinose Inc	2.84	$ 73.362 Millions	$ 25.823 Millions
Amneal Pharmaceuticals Inc	2.82	$ 2,258.884 Millions	$ 802.076 Millions
Viewray Inc	2.81	$ 105.864 Millions	$ 37.656 Millions

Date modified: 2026-10-07T00:41:50+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.